|
Founded: 1978
Founder: William A. Linton, Chairman and CEO
Ownership: Employees and investors; privately held
Number of Employees: 920
Number of Products: 2,000+
Patent Leadership: Promega holds ~200 patents focused in the areas of:
- Nucleic acid purification
- Human identification
- Bioluminescence
- Coupled in vitro transcription and translation
- Cell biology
Licensing: Promega offers licensing opportunities for a number of key technologies.
Currently the following technologies are available for licensing:
- Vector Label License - Green Fluorescent Protein
- Vector Label License - Luciferase
- Apoptosis Marker Antibodies
- Short Tandem Repeats (STRs)
Annual Revenue: Over $220 million
Percent of Revenues Invested in R&D: 11%
|
